Home Cart Sign in  
Chemical Structure| 5081-48-1 Chemical Structure| 5081-48-1

Structure of Ellipticine HCl
CAS No.: 5081-48-1

Chemical Structure| 5081-48-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Ellipticine HCl is a potent antineoplastic agent and inhibits DNA topoisomerase II activities.

Synonyms: NSC 71795 hydrochloride; Ellipticine hydrochloride; PZE

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Ellipticine HCl

CAS No. :5081-48-1
Formula : C17H15ClN2
M.W : 282.77
SMILES Code : CC1=C(C=NC=C2)C2=C(C)C(N3)=C1C4=C3C=CC=C4.[H]Cl
Synonyms :
NSC 71795 hydrochloride; Ellipticine hydrochloride; PZE
MDL No. :MFCD00050600
InChI Key :VSBNVARERCGCEF-UHFFFAOYSA-N
Pubchem ID :169532

Safety of Ellipticine HCl

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Ellipticine HCl

DNA

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
Raji cells 2.5 μM 8 hours Ellipticine alone induced Bax protein expression and apoptosis, and combined treatment with doxorubicin enhanced chemosensitivity Apoptosis. 2011 Mar;16(3):301-10
A549 human lung carcinoma cells 0.005, 0.05, 0.5, 5.0, 50.0 µg/mL 24 and 48 hours To evaluate the antiproliferative effect of EAK-EPT complexes on A549 lung cancer cells. Results showed that EAK-EPT complexes significantly inhibited A549 cell growth more than ellipticine alone, especially after 48 hours of incubation. Int J Nanomedicine. 2012;7:3221-33
NIH-3T3-D55 cells 20 μM 90 minutes To study the effects of Ellipticine on DNA, it was found to induce double strand breaks (DSBs) associated with DNA-protein cross-links (DPLs). Nucleic Acids Res. 1984 Nov 26;12(22):8653-65
HeLa cells 100 μM To study the effect of Ellipticine on adenovirus DNA, it was found that Ellipticine did not induce double-stranded breaks. Nucleic Acids Res. 1992 Aug 11;20(15):4033-8
CV-1 cells 50-100 μM 2 hours To investigate the effect of Ellipticine on the topology of SV40 DNA, it was found that Ellipticine significantly increased the superhelical density of intracellular SV40 DNA. Nucleic Acids Res. 1992 Aug 11;20(15):4033-8

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Balb/c nude mice A549 nude mouse tumor model Intraperitoneal injection EAK-EPT complexes (2:1 mass ratio) with ellipticine concentration of 11.25 mg/kg Once daily for 14 days To evaluate the antitumor effect of EAK-EPT complexes in vivo. Results showed that EAK-EPT complexes significantly inhibited tumor growth without apparent side effects. Int J Nanomedicine. 2012;7:3221-33

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.54mL

0.71mL

0.35mL

17.68mL

3.54mL

1.77mL

35.36mL

7.07mL

3.54mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories